A First-in-human Study to Assess OT-C001 (Amplified/Activated Allogenic Natural Killer Cells) in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT07044050 · RECRUITING
Trial details
- NCT number
- NCT07044050
- Sponsor
- Emercell SAS
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-10
- Primary completion
- 2026-09-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.